TIN is focused on advancing Therapies and
Treatments to benefit those living with an
Inherited Neuropathy.

As a group, these are known as
Charcot-Marie-Tooth (CMT) disorders.

Latest News

Accelerating Answers for CMT Patients

Dr. Mario Bortolozzi TIN has extended our sponsorship of the laboratory of Mario Bortolozzi at the Veneto Institute of Molecular Medicine in a research project aimed directly linking genetic defects of CMTX1 patients, with dysfunction of the protein that is produced...

Topline Results from NMD’s Phase 2a Study of Ignaseclant with CMT patients!

NMD Pharma announces topline results from its Phase 2a study of ignaseclant in Charcot-Marie-Tooth disease Types 1 and 2 Exploratory Phase 2a study showed consistent and clinically meaningful functional improvements across muscle strength, motor performance, and...

TIN-sponsored researcher recognized by Peripheral Nerve Society with prestigious award

Erva Bayraktar, Ph.D. was recently awarded the Peripheral Nerve Society's Laura Feltri Basic Science Fellowship at its annual meeting, held in May in Edinburgh, Scotland. This prestigious grant provides two years of funding to allow a junior scientist to further...

Therapies for Inherited Neuropathies is a registered 501(C)(3) health organization, focused on improving the lives of people with Charcot-Marie-Tooth disease

Solutions Now

Physical therapy videos and articles dedicated to expert insights on the latest treatment options, and practical therapies designed to improve mobility, reduce symptoms, and enhance daily life.

Physical Therapy Self-Help Videos

Physical Therapy Snack Videos

Keep Moving PT Articles

Lifestrength PT Connections Series

Help on the Way

TIN is dedicated to advancing research initiatives to better understand, diagnose, and treat CMT. Collaborating with researchers, clinicians, and the CMT community, we aim to accelerate innovative therapies for those living with CMT.

Research Partners Network

CMT Test in a Dish

Antibody to Stop CMT

Fingolimod to Treat CMT

Exercise Yields Benefits

1:2500

CMT affects 1 in 2500 people, meaning more than three million people world-wide are affected with Charcot Marie Tooth (CMT)

2

Current treatment options are limited to bracing, and surgery in some cases

130,000+

Those affected in the US population. CMT impacts those of all ages, sex, faith or race

Proud of the company we keep

Our Board members and Advisors have made a commitment to contribute their expert skills to a common goal: Improving the lives of members of the CMT community